Urology · Miramar, FL
NPI
1134128267
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1951 SW 172nd Ave, Suite 300
Miramar, FL, 33029
Phone (954) 499-7696
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
2,069 services
Medicare patients, 2024
279
Average age 75
Drug cost, 2024
$766K
3,798 prescriptions
Company payments, 2025
$552
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eliecer Kurzer was code 81003 (clinical chemistry), 479 times for 210 patients. In total Eliecer Kurzer billed 2,069 services in 44 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 479 | 210 | $2.17 | $1,037 |
| 51798 Ultrasound - Nonspecific | Office | 424 | 198 | $8.52 | $3,614 |
| 99214 Office E&M - Established | Office | 268 | 156 | $92.79 | $25K |
| 99213 Office E&M - Established | Office | 193 | 130 | $66.96 | $13K |
| 51741 Test - Miscellaneous | Office | 190 | 106 | $10.04 | $1,908 |
| 99233 Hospital E&M - Subsequent | Facility | 106 | 49 | $87.24 | $9,248 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 87 | 58 | $46.50 | $4,045 |
| 52000 Cystourethroscopy | Office | 45 | 39 | $198.98 | $8,954 |
| 99204 Office E&M - New | Office | 38 | 38 | $111.88 | $4,252 |
| 99215 Office E&M - Established | Facility | 21 | 15 | $123.66 | $2,597 |
| 99223 Hospital E&M - Initial | Facility | 15 | 14 | $127.87 | $1,918 |
By year: 2022 $97K for 3,830 services; 2023 $96K for 2,936 services; 2024 $105K for 2,069 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 479 | 210 | $2.17 | $1,037 |
Medicare prescription drug claims, 2024
In 2024, the drug Eliecer Kurzer prescribed most often to Medicare patients was Tamsulosin Hcl, with 833 prescriptions and refills. In total Eliecer Kurzer wrote 3,798 Medicare prescriptions that cost $766K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 833 | 2,381 | 287 | $11K |
| Finasteride Generic | 514 | 1,468 | 167 | $5,489 |
| Silodosin Generic | 323 | 781 | 104 | $28K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 228 | 635 | 101 | $5,659 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 223 | 572 | 98 | $4,407 |
| Estradiol Generic | 223 | 620 | 106 | $13K |
| Gemtesa Vibegron | 152 | 293 | 45 | $137K |
| Potassium Citrate Er Potassium Citrate | 140 | 391 | 53 | $13K |
| Myrbetriq Mirabegron | 127 | 271 | 33 | $120K |
| Levofloxacin Generic | 118 | 118 | 101 | $326 |
| Methenamine Hippurate Generic | 92 | 227 | 42 | $8,838 |
| Sildenafil Citrate Generic | 79 | 107 | 26 | $512 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 63 | 76 | 45 | $1,485 |
| Dutasteride Generic | 59 | 164 | 18 | $1,615 |
| Oxybutynin Chloride Generic | 56 | 149 | 25 | $754 |
Brand drugs: - claims; generic drugs: 3,402 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eliecer Kurzer $552 ($552 in general payments such as food, travel and fees) from 14 companies. The largest payer was Coloplast Corp with $89.44.
| Company | Payments | Amount |
|---|---|---|
| Coloplast Corp | 4 | $89.44 |
| Janssen Biotech, Inc. JNJ | 4 | $80.37 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $73.4 |
| Boston Scientific Corporation BSX | 1 | $51.33 |
| Antares Pharma, Inc. | 2 | $47.9 |
| Tolmar, Inc. | 2 | $45.17 |
| Urogen Pharma, Inc. URGN | 1 | $26.23 |
| Hologic Sales and Service, LLC HOLX | 1 | $23.43 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $22.83 |
| Calyxo, Inc. | 1 | $19.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.